Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709261 | 0.94 | PTGER4 (0.34) | PTGER4 | |
| SCHEMBL30709275 | 0.91 | KDM4E (0.32) | PTGER4 | |
| SCHEMBL30561087 | 0.84 | PTGER4 (0.35) | PTGER4CYP1A2PIK3CDPIK3CACSF1R | |
| SCHEMBL30709418 | 0.82 | PTGER4 (0.37) | PTGER4CSF1R | |
| SCHEMBL21562834 | 0.82 | PTGER4 (0.35) | PTGER4CYP1A2NPSR1PIK3CDPIK3CA | |
| SCHEMBL30561099 | 0.82 | PTGER4 (0.35) | PTGER4CYP1A2NPSR1PIK3CDPIK3CA | |
| SCHEMBL30709476 | 0.82 | DUSP3 (0.32) | — | |
| SCHEMBL21562774 | 0.81 | KDM4E (0.38) | PTGER4TSPOCYP1A2PIK3CDPIK3CA | |
| SCHEMBL30561149 | 0.81 | KDM4E (0.38) | PTGER4TSPOCYP1A2PIK3CDPIK3CA | |
| SCHEMBL30709248 | 0.81 | NTRK1 (0.33) | NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | PTGER4 1328/4885TSPO 2461/4885CYP1A2 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.